Deqiang Liang et al.
COMMUNICATIONS
Abdel-Kader, T. Verwanger, A. El-Ansary, Eur. J. Med.
Chem. 2010, 45, 372–378.
[9] For selected examples, see: a) M. Wang, F. Han, H.
Yuan, Q. Liu, Chem. Commun. 2010, 46, 2247–2249;
b) J. Tan, X. Xu, L. Zhang, Y. Li, Q. Liu, Angew.
Chem. 2009, 121, 2912–2916; Angew. Chem. Int. Ed.
2009, 48, 2868–2872; c) X. Bi, D. Dong, Q. Liu, W.
Pan, L. Zhao, B. Li, J. Am. Chem. Soc. 2005, 127,
4578–4579; d) Z. Fu, M. Wang, Y. Ma, Q. Liu, J. Liu, J.
Org. Chem. 2008, 73, 7625–7630; e) Y. Ma, M. Wang,
D. Li, B. Bekturhun, J. Liu, Q. Liu, J. Org. Chem. 2009,
74, 3116–3121.
[2] a) E. J. Corey, L. I. Wu, J. Am. Chem. Soc. 1993, 115,
9327–9328; b) A. G. Martinez, L. J. Marco, Bioorg.
Med. Chem. Lett. 1997, 7, 3165–3170; c) W. P. Smith,
L. S. Sollis, D. P. Howes, C. P. Cherry, D. I. Starkey,
N. K. Cobley, J. Med. Chem. 1998, 41, 787–797; d) J.-L.
Wang, D. X. Liu, Z.-J. Zhang, S. M. Shan, X. B. Han,
S. M. Srinivasula, C. M. Croce, E. S. Alnemri, Z. W.
Huang, Proc. Natl. Acad. Sci. USA 2000, 97, 7124–
7129; e) D. R. Anderson, S. Hegde, E. Reinhard, L.
Gomez, W. F. Vernier, L. Lee, S. Liu, A. Sambandam,
P. A. Snider, L. Masih, Bioorg. Med. Chem. Lett. 2005,
15, 1587–1590; f) F. Shaheen, M. Ahmad, S. N. Khan,
S. S. Hussain, S. Anjum, B. Tashkhodjaev, K. Turgunov,
M. N. Sultankhodzhaev, M. I. Choudhary, A. Rahman,
Eur. J. Org. Chem. 2006, 2371–2377; g) S. Sciabola, E.
Carosati, L. Cucurull-Sanchez, M. Baroni, R. Mann-
hold, Bioorg. Med. Chem. 2007, 15, 6450–6462; h) S. X.
Cai, J. Drewe, W. Kemnitzer, Anti-Cancer Agents in
Med. Chem. 2009, 9, 437–456; i) M. Gao, M. Wang,
K. D. Miller, G. D. Hutchins, Q.-H. Zheng, Appl.
Radiat. Isot. 2010, 68, 110–116.
[10] a) H.-J. Yuan, M. Wang, Y.-J. Liu, Q. Liu, Adv. Synth.
Catal. 2009, 351, 112–116, and references cited therein;
b) Y. Liu, M. Wang, H. Yuan, Q. Liu, Adv. Synth.
Catal. 2010, 352, 884–892; c) Y. Yin, M. Wang, Q. Liu,
J. Hu, S. Sun, J. Kang, Tetrahedron Lett. 2005, 46,
4399–4402; d) Q. Zhang, S. Sun, J. Hu, Q. Liu, J. Tan,
J. Org. Chem. 2007, 72, 139 À143.
[11] a) M. Yasuda, T. Somyo, A. Baba, Angew. Chem. 2006,
118, 807–810; Angew. Chem. Int. Ed. 2006, 45, 793–
796; b) K. Motokura, N. Fujita, K. Mori, T. Mizugaki,
K. Ebitani and K. Kaneda, Angew. Chem. 2006, 118,
2667–2671; Angew. Chem. Int. Ed. 2006, 45, 2605–
2609.
[12] For selected examples on the biological activities of di-
hydrocoumarins, see: a) F. Roelens, K. Huvaere, W.
Dhooge, M. Van Cleemput, F. Comhaire, D. De Keuke-
leire, Eur. J. Med. Chem. 2005, 40, 1042–1051; b) X.
Zhang, H. Wang, Y. Song, L. Nie, L. Wang, B. Liu, P.
Shen, Y. Liu, Bioorg. Med. Chem. Lett. 2006, 16, 949–
953; c) K. Takara, A. Kuniyoshi, K. Wada, K. Kinjyo,
H. Iwasaki, Biosci. Biotechnol. Biochem. 2008, 72,
2191–2194.
[13] For recent reports on the synthesis of 3,4-disubstituted
dihydrocoumarins, see: a) S. Duan, R. Jana, J. A.
Tunge, J. Org. Chem. 2009, 74, 4612–4614; b) E.
Alden-Danforth, M. T. Scerba, T. Lectka, Org. Lett.
2008, 10, 4951–4953; c) A. Shaabani, E. Soleimani,
A. H. Rezayan, A. Sarvary, H. R. Khavasi, Org. Lett.
2008, 10, 2581–2584; d) H. Lv, L. You, S. Yea, Adv.
Synth. Catal. 2009, 351, 2822–2826; e) X. Han, X. Lu,
Org. Lett. 2010, 12, 108–111.
[3] a) E. A. Hafez, M. H. Elnagdi, A. G. A. Elagemey,
F. M. A. A. El-Taweel, Heterocycles 1987, 26, 903–907;
b) M. S. Al-Thebeiti, Heterocycles 1999, 51, 1765–2774;
c) J. R. Li, L. J. Zhang, X. Q. Yang, Q. Li, D. Wang,
C. X. Wang, D. X. Shi, Q. Zhang, Chin. Chem. Lett.
2008, 19, 15–18.
[4] a) Y.-L. Shi, M. Shi, Org. Lett. 2005, 7, 3057–3060;
b) G.-L. Zhao, Y.-L. Shi, M. Shi, Org. Lett. 2005, 7,
4527–4530; c) Y.-L. Shi, M. Shi, Chem. Eur. J. 2006, 12,
3374–3378; d) Y.-L. Shi, M. Shi, Org. Biomol. Chem.
2007, 5, 1499–1504; e) X. Zhang, S. Zhang, W. Wang,
Angew. Chem. 2010, 122, 1523–1526; Angew. Chem.
Int. Ed. 2010, 49, 1481–1484.
[5] a) J. S. Yadav, B. V. Subba Reddy, M. K. Gupta, I. Pra-
thap, S. K. Pandey, Catal. Commun. 2007, 8, 2208–
2211; b) M. Costa, F. Areias, L. Abrunhosa, A. Venꢃn-
cio, F. ProenÅa, J. Org. Chem. 2008, 73, 1954–1962;
c) M. N. Elinson, A. S. Dorofeev, F. M. Miloserdov,
A. I. Ilovaisky, S. K. Feducovich, P. A. Belyakov, G. I.
Nikishin, Adv. Synth. Catal. 2008, 350, 591–601.
[6] a) Y. Nishibayashi, Y. Inada, M. Hidai, S. Uemura, J.
Am. Chem. Soc. 2002, 124, 7900–7901; b) W. A. L. V.
Otterlo, E. L. Ngidi, S. Kuzvidza, G. L. Morgans, S. S.
Moleele, C. B. Koning, Tetrahedron 2005, 61, 9996–
10006; c) Y. W. Fang, C. Z. Li, J. Org. Chem. 2006, 71,
6427–6431; d) J, Fan, Z. Wang, Chem. Commun.
2008, 5381–5383.
[14] In all cases except entries 8–12, the coupling product
A, generated from 2a and methanethiol, was always ob-
tained in 20–40% yields (yield based on 1a) along with
the isolation of 4H-chromene 3a..
[7] a) C.-J. Li, Acc. Chem. Res. 2002, 35, 533–538; b) B. M.
Trost, F. D. Toste, A. B. Pinkerton, Chem. Rev. 2001,
101, 2067–2096; c) S. R. Chemler, D. Trauner, S. J.
Danishefsky, Angew. Chem. 2001, 113, 4676–4701;
Angew. Chem. Int. Ed. 2001, 40, 4544–4568; d) K. C.
Nicolaou, P. G. Bulger, D. Sarlah, Angew. Chem. 2005,
117, 4516–4663; Angew. Chem. Int. Ed. 2005, 44, 4442–
4489.
[8] a) M. Shibasaki, M. Kanai, Chem. Rev. 2008, 108,
2853–2873; b) A. Alexakis, J. E. Bꢄckvall, N. Krause,
O. Pꢅmies, M. Diꢆguez, Chem. Rev. 2008, 108, 2796–
2823.
[15] In order to get more proof for the accelerated hydroly-
sis of 3 to 4 in MeCN, we also carried out the reaction
of 1c and 2a in MeCN at lower temperature (408C) for
a shorter reaction time (10 min); 4H-chromene 3k was
isolated only in 45% yield with the formation of the
corresponding hydrolysis product 4f in 27% yield. By
1598
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2010, 352, 1593 – 1599